60 Degrees Pharmaceuticals Inc
(SXTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,598 | -6,178 | -4,508 | -3,058 | -4,260 |
| Depreciation Amortization | 723 | 1,244 | 879 | 377 | 676 |
| Accounts receivable | -37 | N/A | -49 | 96 | N/A |
| Other Working Capital | 740 | 3,306 | 2,158 | 1,462 | 2,896 |
| Other Operating Activity | 760 | 618 | 577 | 486 | 39 |
| Operating Cash Flow | $-413 | $-1,010 | $-944 | $-637 | $-649 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -33 | -2 | -3 | -35 |
| Other Investing Activity | 0 | -27 | 0 | 0 | 0 |
| Investing Cash Flow | $-3 | $-60 | $-2 | $-3 | $-35 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 200 | N/A | 1,105 | 800 | N/A |
| Debt Repayment | N/A | N/A | 0 | 305 | N/A |
| Common Stock Issued | N/A | N/A | 185 | 185 | N/A |
| Other Financing Activity | -18 | 1,222 | 0 | 0 | 611 |
| Financing Cash Flow | $182 | $1,222 | $1,290 | $1,290 | $611 |
| Exchange Rate Effect | -1 | -2 | -21 | -14 | -3 |
| Beginning Cash Position | 265 | 115 | 115 | 115 | 192 |
| End Cash Position | 30 | 265 | 439 | 752 | 115 |
| Net Cash Flow | $-235 | $150 | $324 | $636 | $-76 |
| Free Cash Flow | |||||
| Operating Cash Flow | -413 | -1,010 | -944 | -637 | -649 |
| Capital Expenditure | -3 | N/A | -2 | -3 | N/A |
| Free Cash Flow | -416 | -1,010 | -946 | -640 | -649 |